¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen cycle"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endogenous cycle
    ³»ÀÎÁÖ±â
  • epidemic cycle
    À¯Çà¼øÈ¯
  • erythrocytic cycle
    ÀûÇ÷±¸³»¹ßÀ°°í¸®
  • estrous cycle
    ¹ßÁ¤ÁÖ±â
  • free-living cycle
    ÀÚÀ¯»ýȰ°í¸®
  • glucose lactate cycle
    Æ÷µµ´çÁ¥»ê¿°È¸·Î
  • gonadotrophic cycle
    »ý½Ä»ùÀÚ±ØÁÖ±â, »ý½Ä¼±ÀÚ±ØÁÖ±â
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
  • growth cycle
    Áõ½ÄÁÖ±â
  • infection cycle
    °¨¿°°í¸®, °¨¿°»ç
  • life cycle
    »ýȰÁÖ±â
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
  • metabolic cycle
    ´ë»çÁÖ±â
  • nasal cycle
    ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
  • nitrogen cycle
    Áú¼Ò¼øÈ¯, Áú¼Ò»çÀÌŬ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð
  • home oxygen therapy
    °¡Á¤»ê¼Ò¿ä¹ý
  • oxygen tension
    »ê¼ÒºÐ¾Ð, »ê¼ÒÀå·Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • epidemic cycle
    À¯Çà¼øÈ¯
  • erythrocytic cycle
    ÀûÇ÷±¸³»¹ßÀ°°í¸®
  • estrous cycle
    ¹ßÁ¤ÁÖ±â
  • exoerythrocytic cycle
    ÀûÇ÷±¸¿Ü¹ßÀ°°í¸®
  • free-living cycle
    ÀÚÀ¯»ýȰ°í¸®
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»êȸ·Î
  • gonadotrophic cycle
    »ý½Ä»ùÀÚ±ØÁÖ±â
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
  • growth cycle
    Áõ½ÄÁÖ±â
  • infection cycle
    °¨¿°»ç, °¨¿°°í¸®
  • life cycle
    »ýȰÁÖ±â, »ýȰ°í¸®
  • metabolic cycle
    ´ë»çÁÖ±â
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
  • nasal cycle
    ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
  • oogenetic cycle
    (¢¡ovarian cycle) ³­¼ÒÁÖ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hair cycle
    ¸ð¹ßÁÖ±â(Ù¾ ñÎÑ¢)
  • hydrogen cycle
    ¼ö¼Òȯ(¡­ü»), ¼ö¼Ò°í¸®.
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • photochemical cycle
    ±¤È­Çаæ·Î(¡­ÌèÖØ).
  • pulse cycle
    ¸Æ¹ÚÁÖ±â(ØæÚÑñ²Ñ¢).
  • BOD=ÊÝbiochemical oxygen demand
    »ý¹°È­ÇÐÀû »ê¼Ò¿ä±¸·®.
  • Helium-oxygen mixture
    Çï·ý»ê¼ÒÈ¥ÇÕü
  • Hemoglobin-oxygen equilibrium curve
    Çì¸ð±Û·Îºó-»ê¼Ò°î¼±
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • PAO2 => alveolar oxygen pressure
    ÆóÆ÷(øËøà)»ê¼Ò¾Ð
  • So2=>oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • altered oxygen affinity
    »ê¼Òģȭ¼º º¯¼º
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷.
  • alveolar-arterial oxygen difference
    ÆóÆ÷-µ¿¸Æ »ê¼ÒÂ÷ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle
    ¼¼Æ÷ÁÖ±â(¡­ñ²Ñ¢).
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle time
    ¼¼Æ÷ÁÖ±â½Ã°£
  • citric acid cycle
    ±¸¿¬»êȸ·Î(Ï®¿¬ß«üÞÖØ)
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®·Î»êȸ·Î.
  • citric acid cycle
    ±¸¿¬»êȸ·Î
  • curing cycle
    ¿Â¼º±â(è®à÷Ñ¢).
  • cycle
    ÁÖ±â(ñÎÑ¢), »çÀÌŬ, Ç츣Âê À½ÀÇ´ÜÀ§ , ¼øÈ¯(°úÁ¤), ȸ·Î.
  • cycle
    ÁÖ±â (ñÎÑ¢)
  • cycle of generation
    ¼¼´ëÁÖ±â(á¦ÓÛñÎÑ¢).
  • cycle of ontogenesis
    °³Ã¼¹ß»ýÁÖ±â
  • cycle per second
    Ãʰ£Áøµ¿¼ö.
  • cycle per second(=cps, Hz)
    Ãʰ£(ôøÊÊ)Áøµ¿¼ö(òÉÔÑâ¦).
  • cycle, growth
    Áõ½ÄÁÖ±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arginine cycle
    ¾Æ¸£Áö´Ñ ȸ·Î(üÞÖØ)
  • ATP-ADP cycle
    ATP-ADP ȸ·Î(üÞÖØ)
  • C4 acid cycle
    C4 »ê(ß«) ȸ·Î(üÞÖØ)
  • Calvin cycle
    Ä®ºó ȸ·Î(üÞÖØ)
  • carbon cycle
    ź¼Ò ȸ·Î(÷©áÈüÞÖØ)
  • carbon-fixation cycle
    ź¼Ò°íÁ¤ ȸ·Î(÷©áÈͳïÒüÞÖØ)
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • cell cycle
    ¼¼Æ÷ÁÖ±â(á¬øàñÎÑ¢)
  • citrate cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • Cori cycle
    ÄÚ¸® ȸ·Î(üÞÖØ)
  • cycle
    "°í¸®, ȸ·Î(üÞÖØ), ȯ»ó(ü»ßÒ)"
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • elongation cycle
    ¿¬ÀåÁÖ±â (æÅíþñÎÑ¢)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PaO2 partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood
QO2 oxygen quotient; oxygen utilization
MCD   1) Minimal Change Disease
  2) Menstrual Cycle Day
BCL basic cycle length; B-cell leukemia/lymphoma
BRAC basic rest-activity cycle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CL Cycle Length
SCL Sinus Cycle Length
SSC Stretch-shortening cycle
CDC2 cell division cycle 2
C cycle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
    »ý¹°ÀÇ »ýȰ»ç¿¡ ÀÖ¾î ÀÏ·ÃÀÇ Çö»ó.
  • menstrual cycle
    ¿ù°æ ÁÖ±â
    ¿©¼º ¹× ÀϺΠ¿µÀå·ù ¾ÏÄÆÀÇ »ý½Ä±â Áß¿¡ ÀϾ´Â Àڱà ³»¸·ÀÇ ±ÔÄ¢ÀûÀÎ »ý¸®ÇÐÀû º¯È­À̸ç, Àڱà ³»¸·ÀÇ ÀϺΰ¡ Å»¶ôµÇ°í ÀϺÎÀÇ Ç÷¾×ÀÌ ÁúÀ» ÅëÇØ ¹èÃâµÈ´Ù.
  • menstural cycle
    ¿ù°æ ÁÖ±â
    ¿ù°æ ÁÖ±â´Â ¿ù°æ ÃâÇ÷ °³½Ã ù³¯ºÎÅÍ ´ÙÀ½ ¿ù°æ ÃâÇ÷ °³½Ã Àü³¯±îÁöÀÇ Àϼö¸¦ ¸»Çϸç, ¿ù°æ ÃâÇ÷ÀÌ ³¡³­ ÈÄ¿¡ ¼¼´Â °ÍÀº ¾Æ´Ï´Ù. Á¤»ó ÁÖ±â´Â 25~38ÀÏÀ̶ó°í »ý°¢ÇÏ¸é µÇ°í, ±âÃÊ Ã¼¿ÂÀÇ Àú¿Â»ó¿¡ ÇØ´çÇÏ´Â ¿©Æ÷±â
  • metabdic cycle
    ´ë»ç ÁÖ±â
  • mitotic cycle
    À¯»ç ºÐ¿­ ȯ
  • muscle pain cycle
    ±ÙÅëÁõ ÁÖ±â, ±Ùµ¿Åë ÁÖ±â
  • nitrogen cycle
    Áú¼Ò ¼øÈ¯
  • ovulation cycle
    ¹è¶õ ÁÖ±â
  • pulse cycle
    ¸Æ¹Ú ÁÖ±â
  • self-generating pain cycle
    µ¿ÅëÀ» À¯¹ßÇÏ´Â ÀÚ¹ßÀûÀÎ ¼øÈ¯ °úÁ¤
  • sulfur cycle
    Ȳ ¼øÈ¯
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼Ò ºÐ¾ÐÂ÷
  • alveolar-arterial oxygen difference
    ÆóÆ÷-µ¿¸Æ »ê¼Ò Â÷ÀÌ
  • biochemical oxygen demand
    »ý¹°È­ÇÐÀû »ê¼Ò ¿ä±¸, »ý¹°È­ÇÐÀû »ê¼Ò ¿ä±¸·®
  • bridging oxygen atom
    °¡±³ »ê¼Ò
    2°³ÀÇ ±Û¶ó½º Çü¼º ¿øÀÚ¸¦ ¿¬°áÇÏ´Â »ê¼Ò.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
singlet oxygen An energised but uncharged form of oxygen that is produced in the metabolic burst of leucocytes and that can be toxic to cells.
(18 Nov 1997)
dissolved oxygen <biochemistry> The concentration of oxygen dissolved in water, expressed in mg/l or as percent saturation, where saturation is the maximum amount of oxygen that can theoretically be dissolved in water at a given altitude and temperature.
(11 Jan 1998)
oxygen 1. <chemistry> A colourless, tasteless, odorless, gaseous element occurring in the free state in the atmosphere, of which it forms about 23 per cent by weight and about 21 per cent by volume, being slightly heavier than nitrogen. Symbol O. Atomic weight 15.96.
It occurs combined in immense quantities, forming eight ninths by weight of water, and probably one half by weight of the entire solid crust of the globe, being an ingredient of silica, the silicates, sulphates, carbonates, nitrates, etc.
Oxygen combines with all elements (except fluorine), forming oxides, bases, oxyacid anhydrides, etc, the process in general being called oxidation, of which combustion is only an intense modification.
at ordinary temperatures with most substances it is moderately active, but at higher temperatures it is one of the most violent and powerful chemical agents known. It is indispensable in respiration, and in general is the most universally active and efficient element.
It may be prepared in the pure state by heating potassium chlorate. This element (called dephlogisticated air by Priestley) was named oxygen by Lavoisier because he supposed it to be a constituent of all acids. This is not so in the case of a very few acids (as hydrochloric, hydrobromic, hydric sulphide, etc), but these do contain elements analogous to oxygen in property and action. Moreover, the fact that most elements approach the nearer to acid qualities in proportion as they are combined with more oxygen, shows the great accuracy and breadth of Lavoisier's conception of its nature.
Pharmacologic action: Increases the supply of oxygen to ischemic tissues. It is the most effective agent in emergency cardiac care.
Uses: Always administer oxygen during emergency cardiac care.
Dose: Nasal cannula with oxygen flow of 4 liters per minute provides FiO2 of about 30%. Nasal cannula with oxygen flow of 6-8 liters per minute provides FiO2 of 35-40%. Venturi mask can provide higher and more precise oxygen concentrations.
Potential complications: Ensure that oxygen is being delivered. Carefully check all connections. Oxygen toxicity develops only after several days of exposure to high FiO2. Increased FiO2 may cause hypoventilation in COPD patients dependent on hypoxic ventilatory drive. This is very rare and simply requires starting at lower FiO2, careful observation, and assisted ventilation if necessary.
Origin: F. Oxygene, from Gr. Sharp, acid + root of to be born. So called because originally supposed to be an essential part of every acid.
(17 Mar 2000)
oxygen-15 A cyclotron-produced, positron-emitting radioisotope of oxygen with a half-life of 122.2 seconds; used in studies of respiratory function and in positron emission tomography.
(05 Mar 2000)
oxygen-16 The common oxygen isotope, making up 99.76% of natural oxygen.
(05 Mar 2000)
oxygen-17 The rarest of the stable oxygen isotopes, making up 0.04% of natural oxygen.
(05 Mar 2000)
oxygen-18 A stable oxygen isotope making up 0.20% of natural oxygen; used in mass spectrometry and in NMR studies of tissue.
Synonym: heavy oxygen.
(05 Mar 2000)
oxygen affinity anoxia Anoxia due to inability of haemoglobin to release oxygen.
(05 Mar 2000)
oxygen affinity hypoxia Hypoxia due to reduced ability of haemoglobin to release oxygen.
(05 Mar 2000)
oxygen capacity The maximum quantity of oxygen that will combine chemically with the haemoglobin in a unit volume of blood; normally it amounts to 1.34 ml of O2 per gm of Hb or 20 ml of O2 per 100 ml of blood.
(05 Mar 2000)
oxygen compounds Inorganic compounds that contain oxygen as an integral part of the molecule.
(12 Dec 1998)
oxygen consumption The rate at which oxygen is used by a tissue; microliters of oxygen stpd used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body.
(12 Dec 1998)
oxygen debt The extra oxygen (compared with its usual oxygen intake at rest) an organismconsumes after a period of strenouousphysical activity.
(09 Oct 1997)
oxygen deficit The difference between oxygen uptake of the body during early stages of exercise and during a similar duration in a steady state of exercise; sometimes considered as the formation of the oxygen debt.
(05 Mar 2000)
oxygen dependent killing One of the most important bactericidal mechanisms of mammalian phagocytes involves the production of various toxic oxygen species (hydrogen peroxide, superoxide, singlet oxygen, hydroxyl radicals) through the metabolic burst. Although anaerobic killing is possible, the oxygen dependent mechanism is crucial for normal resistance to infection and a defect in this system is usually fatal within the first decade of life (chronic granulomatous disease).
See: myeloperoxidase, chemiluminescence.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • estrous cycle
    (µ¿)¹ßÁ¤±â
  • family life cycle
    °¡Á· ÁÖ±â
  • food cycle
    ¸ÔÀ̼øÈ¯
  • fuel cycle
    (ÇÙÀÇ) ¿¬·á »çÀÌŬ
  • heliacal cycle
    ÅÂ¾ç ¼øÈ¯±â
  • nitrogen cycle
    Áú¼Ò ¼øÈ¯
  • product life cycle
    Á¦Ç°ÀÇ ¶óÀÌÇÁ »çÀÌŬ
  • solar cycle
    ÅÂ¾ç ¼øÈ¯±â;28 ÁÖ³â
  • trade cycle
    °æ±â ¼øÈ¯
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á